Apogenix.com
| Top pog sites |
| Top enix sites |
- Title
- Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer and other malignant diseases
- Meta Description
- Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
- Meta Keywords
- cancer, malignant diseases, oncology, oncological, hematology, hematological, protein therapeutics, APG101, glioblastoma, phase II trial, phase II study, efficacy, solid tumors, myelodysplastic syndromes, MDS, phase I trial, phase I study, CD95 ligand inhibitors, APG880, TRAIL receptor agonists, technology platform, tumor necrosis factor superfamily, TNFSF, immunotherapy, cancer immunotherapy, checkpoint inhibitor, clinical development, research, brain tumor
- Technologies in use
- Joomla, MooTools, jQuery, spin.js, Piwik
| Content-Type | text/html; charset=u |
| Transfer-Encoding | chunked |
| Connection | keep-alive |
| Keep-Alive | timeout=15 |
| Server | Apache |
| X-Powered-By | PHP/7.0.27 |
| P3P | CP="NOI ADM DEV PSAi |
| Expires | Wed, 17 Aug 2005 00: |
| Cache-Control | no-store, no-cache, |
| Pragma | no-cache |
| Last-Modified | Wed, 21 Feb 2018 13: |
| Content-Encoding | gzip |